Drugs / Folitropin Beta
Folitropin Beta
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT06193135 Comparator | Jul → Dec 2025 overdue | female infertility | Instituto Valenciano de Infertilidad, IVI VALENCIA | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Folitropin Beta | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06193135 ↗ |
| Known as | Folitropin β | “Patients will undergo controlled ovarian stimulation with Folitropin β (Puregon) + Progevera 10 mg.” NCT06193135 ↗ |
| Known as | follitropin β | “daily dose of rFSH (follitropin β) as a control” NCT06193135 ↗ |
| Modality | Protein / enzyme biologic | “daily dose of rFSH (follitropin β) as a control” NCT06193135 ↗ |